Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    Chosa

    MCap

    SEK83m

    Last close

    SEK1.05

    ▲ 0.12 (12.90%)

    Substrate AI

    MCap

    EUR15m

    Last close

    EUR0.09

    ▲ 0.01 (12.66%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

AFT Pharmaceuticals — Bull, Bear & Beyond – AFT Pharmaceuticals: executive interview

AFT Pharmaceuticals — Bull, Bear & Beyond – AFT Pharmaceuticals: executive interview

AFT Pharmaceuticals — 1 video in collection

More on this equity

AFT Pharmaceuticals (NZX: AFT) is a commercial-stage specialty pharma company with strong roots in Australasia, its own salesforce and a growing global presence through licensing and distribution agreements. The product portfolio is a mix of own-branded, generic and in-licensed products across various therapeutic areas, targeting the over-the-counter, hospital and prescription segments. AFT is profitable and dividend distributing, with NZ$200m in revenues expected to be achieved in CY24 and a rolling target of NZ$300m.

Listen on your preferred podcast player below:

About Bull, Bear & Beyond: Each episode features candid conversations with senior executives and from our own team of experts from across industries, exploring strategy, innovation, and the opportunities shaping their markets and 60-second pieces are a compressed summary of content designed to convey our message in a single, easily shareable hit.

< Previous

You may also be interested in these:

Healthcare

Bull, Bear & Beyond – Medigene: executive interview

Healthcare

Bull, Bear & Beyond – IRLAB Therapeutics: executive interview